Anti-aggregatory prostanoids. Part I.
Properties of several products of cyclo-oxygenation of polyunsaturated fatty acids: prostacyclin, prostaglandins 6-keto E1, E2, D2, D3 are reviewed in relation to their antiplatelet activity.
D000527:Alprostadil / Q000031:analogs & derivatives / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D011464:Epoprostenol / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D015230:Prostaglandin D2; D011457:Prostaglandins D / Q000494:pharmacology; D011466:Prostanoic Acids / Q000494:pharmacology*
D005227:Fatty Acids; D011457:Prostaglandins D; D011466:Prostanoic Acids; C022950:6-ketoprostaglandin E1; C027005:prostaglandin D3; D011464:Epoprostenol; D000527:Alprostadil; D015230:Prostaglandin D2